NeuroOne Medical Technologies (NMTC) EBITDA (2009 - 2026)
NeuroOne Medical Technologies (NMTC) EBITDA from Dec 31, 2009 to Mar 31, 2026. The TTM NeuroOne Medical Technologies (NMTC) EBITDA is -$6.82M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
NeuroOne Medical Technologies (NMTC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +7.91% |
| 3 Years TTM | -9.85% |
| 5 Years TTM | +1.99% |
| 10 Years TTM | +63.49% |
| All Time TTM | +46.59% |
Annual EBITDA change of NeuroOne Medical Technologies (NMTC)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$2.05M | -48.23% |
| 2025 | -$3.96M | -65.98% |
| 2024 | -$12M | -1.02% |
| 2023 | -$12M | +18.67% |
| 2022 | -$9.91M | -2.27% |
| 2021 | -$10M | +109.07% |
| 2020 | -$4.85M | -16.23% |
| 2019 | -$5.79M | +45.84% |
| 2018 | -$3.97M | -21.54% |
| 2017 | -$5.06M | +10020.00% |
| 2016 | -$50K | N/A |
| 2015 | -$50K | +25.00% |
| 2014 | -$40K | +33.33% |
| 2013 | -$30K | N/A |
| 2012 | -$30K | N/A |
| 2011 | -$30K | +200.00% |
| 2010 | -$10K | N/A |
| 2009 | $0 | N/A |
Comparison NeuroOne Medical Technologies (NMTC) five years EBITDA CAGR with competitors
NeuroOne Medical Technologies (NMTC) five years EBITDA CAGR is 1.94%.